Edan Instruments

Edan Instruments Accounts Payable

The Accounts Payable of Edan Instruments (300206.SZ) as of Oct 27, 2026 is 197.38 M CNY. In the previous year, Accounts Payable was 179.51 M CNY — a change of 9.95% (higher).

Accounts Payable

197.38 MCNY

YoY

9.95%

Last updated:

Accounts Payable of Edan Instruments is 2025 197.38 M CNY. Accounts Payable of Edan Instruments was 2024 179.51 M CNY. It decreases by 9.95% higher compared to the previous year.

The Edan Instruments Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
71.91 M CNY
Jan 1, 2019
101.19 M CNY
Jan 1, 2020
126.60 M CNY
Jan 1, 2021
113.59 M CNY
Jan 1, 2022
130.75 M CNY
Jan 1, 2023
90.33 M CNY
Jan 1, 2024
179.51 M CNY
Jan 1, 2025
197.38 M CNY
The Edan Instruments Accounts Payable history
YEARAccounts PayableYoY
197.38 MCNY+9.95%
179.51 MCNY+98.73%
90.33 MCNY-30.91%
130.75 MCNY+15.10%
113.59 MCNY-10.27%
126.60 MCNY+25.10%
101.19 MCNY+40.72%
71.91 MCNY+22.98%
58.47 MCNY+8.82%
53.73 MCNY+2.73%
52.31 MCNY+22.42%
42.73 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Edan Instruments Stock analysis

What does Edan Instruments do? Edan Instruments, Inc. generates revenue through the design, manufacture, and sale of medical equipment, including maternity product series like doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors, and maternity integrated diagnostic monitoring systems. The company also sells electrocardiograph series such as digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, and electrocardiographic workstations, along with monitoring products like portable multi-variable monitors and central monitoring systems. Additionally, Edan offers spare parts and in vitro diagnostics products to support its equipment and medical services. The primary buyers of Edan's products are healthcare institutions, including hospitals and clinics, which purchase medical devices for diagnostic and monitoring purposes. These institutions rely on Edan's maternity, electrocardiograph, and monitoring systems to provide patient care. The company's in vitro diagnostics products are also sold to medical facilities for laboratory testing needs. Edan's product segments are defined by medical equipment categories: maternity, electrocardiograph, monitoring, and ultrasonic image systems. The spare parts and in vitro diagnostics businesses complement these segments by providing essential accessories and diagnostic tools. Revenue is derived from direct sales of these products to healthcare providers, with no mention of third-party distribution or additional services beyond the described offerings. Edan Instruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edan Instruments stock

Accounts Payable of Edan Instruments is 197.38 M CNY in 2025.

Accounts Payable of Edan Instruments changed from 179.51 M CNY to 197.38 M CNY, representing a 9.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Edan Instruments since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Edan Instruments historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Edan Instruments

All Key Metrics — Edan Instruments